A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC)

被引：0
|
作者：
Griffith, David [1 ]
Flume, Patrick [2 ]
Winthrop, Kevin [3 ]
Thomson, Rachel [4 ]
Wagner, Dirk [5 ,6 ]
Van Ingen, Jakko [7 ]
Micioni, Liza [8 ]
McGinnis, John P., II [8 ]
Fernandez, Carlos [8 ]
Eagle, Gina [8 ]
机构：
[1] Univ Texas Hlth Sci Ctr Tyler, Dept Med, Tyler, TX 75799 USA
[2] Med Univ South Carolina, Div Pulm Crit Care & Sleep Med, Charleston, SC 29425 USA
[3] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA
[4] Greenslopes Private Hosp, Gallipoli Med Res Ctr, Thorac Med, Brisbane, Qld, Australia
[5] Univ Med Ctr, Ctr Infect Dis & Travel Med, Freiburg, Germany
[6] Univ Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany
[7] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, Nijmegen, Netherlands
[8] Insmed Inc, Clin, Bridgewater, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Bacteria; Infections; Treatments;
D O I：
10.1183/13993003.congress-2015.PA3945
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3945
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients
    Griffith, D. E.
    Eagle, G.
    Thomson, R. M.
    Aksamit, T. R.
    Hasegawa, N.
    Morimoto, K.
    Addrizzo-Harris, D. J.
    O'Donnell, A. E.
    Marras, T. K.
    Flume, P. A.
    Loebinger, M. R.
    Morgan, L. C.
    Castellotti, P. F.
    Hill, A. T.
    Ruoss, S. J.
    Yim, J. J.
    Ringshausen, F. C.
    Field, S. K.
    Nezamis, J.
    Winthrop, K. L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] AN OPEN-LABEL EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Morimoto, Kozo
    Castellotti, Paola Francesca
    Yim, Jae-Joon
    Ruoss, Stephen
    van Ingen, Jakko
    Coulter, Christopher
    Mange, Kevin
    Nezamis, James
    Griffith, David
    [J]. CHEST, 2019, 156 (04) : 146A - 147A
  • [3] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OPEN-LABEL STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (LAI) IN PATIENTS WITH RECALCITRANT NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE (NTM-LD)
    Olivier, K. N.
    Eagle, G.
    McGinnis, J. P., II
    Micioni, L.
    Daley, C. L.
    Winthrop, K. L.
    Ruoss, S.
    Addrizzo-Harris, D. J.
    Flume, P.
    Dorgan, D.
    Salathe, M. A.
    Brown-Elliot, B. A.
    Wallace, R.
    Griffith, D. E.
    [J]. PEDIATRIC PULMONOLOGY, 2014, 49 : 321 - 321
  • [4] Subject And Site Recruitment From The Global Phase Iii Study Of Liposomal Amikacin For Inhalation (lai) In Adult Patients With Lung Infections Caused By Mycobacterium Avium Complex (mac) Who Have Not Improved With Previous Treatments (convert Study)
    Griffith, D. E.
    Winthrop, K. L.
    Morimoto, K.
    Hasegawa, N.
    Codecasa, L.
    Hoefsloot, W.
    Burke, A.
    Yim, J. -J.
    Yuen, D.
    Nowicke, D.
    Mooney, L.
    Dudek, A.
    Eagle, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] Subgroup Analyses Of Baseline Demographics And Efficacy In Patients With Refractory Nontuberculous Mycobacteria (ntm) Lung Infection Treated With Liposomal Amikacin For Inhalation (lai)
    Winthrop, K. L.
    Eagle, G.
    McGinnis, J. P.
    Micioni, L.
    Daley, C. L.
    Ruoss, S. J.
    Addrizzo-Harris, D. J.
    Flume, P. A.
    Dorgan, D. J.
    Salathe, M.
    Brown-Elliott, B. A.
    Wallace, R. J.
    Griffith, D. E.
    Olivier, K. N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [6] Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex
    Swenson, Colin
    Del Parigi, Angelo
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (01) : 201 - 202
  • [7] Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)
    Winthrop, K. L.
    Eagle, G.
    Thomson, R. M.
    Aksamit, T. R.
    Hasegawa, N.
    Morimoto, K.
    Addrizzo-Harris, D. J.
    O'Donnell, A. E.
    Marras, T. K.
    Flume, P. A.
    Loebinger, M. R.
    Morgan, L. C.
    Codecasa, L. R.
    Hill, A. T.
    Ruoss, S. J.
    Yim, J. J.
    Ringshausen, F. C.
    Field, S. K.
    Nezamis, J.
    Griffith, D. E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [8] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157
  • [9] EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Eagle, Gina
    Morimoto, Kozo
    Castellotti, Paola Francesca
    O'Donnell, Anne
    Ruoss, Stephen
    Aksamit, Timothy
    Nezamis, James
    Griffith, David
    [J]. CHEST, 2018, 154 (04) : 182A - 183A
  • [10] Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium avium Complex (MAC)
    Shah, Anuj
    Ng, Xinyi
    Shah, Ruchit
    Solem, Caitlyn
    Wang, Ping
    Obradovic, Marko
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2021, 12 : 45 - 54
12345